The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris.

Yan Li; Linde Jing; Yishi Li; Jinfa Jiang; Zhirong Wang; Jin Wei; Xingtao Li; Lin Wang; Hao Xia; Tianfa Li; Shaowen Liu; Bo Xing; Zhenyu Yang; Qinghua Lu; Rongjian Jiang; Ping Xie; Xiling Shou; Xiaofeng Wang; Youhong Jia

首页> 外文期刊>Pharmacoepidemiology and drug safety >The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris.

【24h】

The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris.

机译：Ivabradine盐酸含量与阿替洛尔在中国慢性稳定心绞痛患者中的疗效和安全性。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Iva is effective in reducing heart rates and improving exercise capacity and noninferior to Aten in Chinese patients with chronic stable angina pectoris. Iva is well tolerated and safe. Copyright ? 2014 John Wiley & Sons, Ltd.

机译：IVA有效地减少了心率和改善了中国慢性稳定心绞痛患者的慢性稳定心绞痛患者的运动能力和不合理。 IVA是良好的耐受性和安全的。版权？ 2014年John Wiley＆Sons，Ltd。

著录项

来源
《Pharmacoepidemiology and drug safety》 |2014年第11期|共9页
作者
Yan Li; Linde Jing; Yishi Li; Jinfa Jiang; Zhirong Wang; Jin Wei; Xingtao Li; Lin Wang; Hao Xia; Tianfa Li; Shaowen Liu; Bo Xing; Zhenyu Yang; Qinghua Lu; Rongjian Jiang; Ping Xie; Xiling Shou; Xiaofeng Wang; Youhong Jia;
展开▼
作者单位

Center of Clinical Pharmacology Key Laboratory of Clinical Trial Research in Cardiovascular Drugs;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris. [J] . Yan Li, Linde Jing, Yishi Li, Pharmacoepidemiology and drug safety . 2014,第11期

机译：盐酸伊伐布雷定与阿替洛尔在中国慢性稳定型心绞痛患者中的疗效和安全性。
2. Beta-blocker dose up-titration or addition of ivabradine in stable angina: more is not necessarily better : editorial to: "efficacy of ivabradine in combination with beta-blocker versus uptitration of beta-blocker in patients with stable angina" by E. Amosova et al. [J] . Sy RW, Freedman SB Cardiovascular drugs and therapy . 2011,第6期

机译：在稳定型心绞痛中增加β受体阻滞剂的剂量或增加伊伐布雷定：不一定并不一定更好：社论作者：E。Amosova：“在稳定型心绞痛患者中，伊伐布雷定联合β受体阻滞剂的疗效与增加β阻滞剂的疗效”等。
3. Beta-Blocker Dose Up-Titration or Addition of Ivabradine in Stable Angina: More is Not Necessarily Better Editorial to: “Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina” by E. Amosova et al. [J] . Raymond W. Sy, Saul B. Freedman Cardiovascular Drugs and Therapy . 2011,第6期

机译：在稳定型心绞痛中使用β-受体阻滞剂剂量增加或添加伊伐布雷定：未必一定会更好：社论作者：E。Amosova等人撰写的文章：“伊伐布雷定与β-受体阻滞剂联用对稳定心绞痛患者的β-阻滞剂增效”等
4. Inflammatory cytokines as a new targets of cardiac remodeling in patients with chronic stable angina in elderly patients [C] . Donetskya O., Tulupova V., Shuldeshova N., European Congress of Pharmacology . 2012

机译：炎症细胞因子作为老年患者慢性稳定心绞痛患者心脏重塑的新靶标
5. Emergency department utilization among adult patients diagnosed with chronic pain and depression from an urban safety-net patient population. [D] . Enad, Racquel. 2016

机译：城市安全网患者人群中被诊断患有慢性疼痛和抑郁症的成年患者中的急诊科服务。
6. A double blind placebo controlled comparison of verapamil atenolol and their combination in patients with chronic stable angina pectoris. [O] . I N Findlay, K MacLeod, G Gillen, 1987

机译：慢性稳定型心绞痛患者的维拉帕米阿替洛尔及其组合的双盲安慰剂对照比较。
7. Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina [O] . Jean-Claude Tardif, Ian Ford, Michal Tendera, 2005

机译：与慢性稳定心绞痛患者的阿米洛尔相比，Ivabradine的疗效，一种新的选择性IF抑制剂

The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris.

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅